Live
- Protesters clash with police in J&K’s Katra town
- Senior Bengaluru Police Officer Accused in Suicide of Businesswoman S Jeeva
- Sidhu makes U-turn, says wife underwent cancer treatment along with Ayurveda-based diet
- Demand for entry-level talent surges 59 pc in India’s tech sector
- AIIMS adds 2 new MRI machines to provide more efficient & timely radiology diagnosis
- Ram Gopal Varma evades police questioning
- NFR's top Safety Officer missing after being swept away in Arunachal Pradesh's Lohit River
- Sensex closes up by 992 points, Adani Ports, L&T top gainers
- Heatwave driving elevated blackout risk in Australia's most populous state
- Two autopsy assistants of RG Kar arrested on extortion charges
Mother's antibacterial soap use may affect baby's gut bacteria
Use of antibacterial bar soap, especially those containing a compound called triclocarban (TCC), during pregnancy and breast-feeding may alter the offspring\'s composition of intestinal bacteria and other micro-organisms, called the gut microbiota, a study warns.
Use of antibacterial bar soap, especially those containing a compound called triclocarban (TCC), during pregnancy and breast-feeding may alter the offspring's composition of intestinal bacteria and other micro-organisms, called the gut microbiota, a study warns.
The gut microbiota contains both beneficial and harmful microbes, and changes in its normal composition are linked to diseases including obesity, diabetes, irritable bowel disease, colon cancer, multiple sclerosis and asthma.
TCC is frequently added to antibacterial bar soap.
Many antibacterial personal care products are commonly used during pregnancy and by nursing women to protect against infectious disease, said the study's lead author Rebekah Kennedy from University of Tennessee, Knoxville, US.
"Our research adds to the growing body of scientific literature suggesting unintended health consequences related to nonprescription antimicrobial use and will allow pregnant and nursing mothers to make informed decisions regarding use of these antimicrobial products," she said.
The findings were presented at the Endocrine Society's 98th annual meeting in Boston, US.
In previous work, Kennedy and her colleagues found that TCC passes through breast milk from rat mothers to their young, an exposure pathway that is relevant to humans.
In their new work, the investigators studied the consequences of TCC exposure early in life on gut microbiota.
The researchers fed female rats chow supplemented with TCC throughout pregnancy and a 16-day nursing period after the rat pups were born.
The investigators performed DNA sequencing of the gut microbiota from the collected samples. They compared the results with gut microbiota analysis of rats and their pups that were not exposed to TCC.
By postnatal day 16, the pups exposed to TCC had a significantly different composition of gut microbiota from that of unexposed pups. Those differences became noticeable starting at day 12, according to the study.
"The ability of TCC antimicrobial exposure to change the composition of the microbial community warrants future investigation to determine the health outcomes resulting from TCC exposure during sensitive windows of prenatal development and early life," Kennedy said.
